BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  World’s First Gene Therapy, IPO, Major Merger - Spark’s CEO Leaves a Legacy

  Jeffrey D. Marrazzo, the co-founder of Spark Therapeutics, is stepping down as CEO of the company. The current COO, Ron Philip, will replace him.

  February 24, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Tiny COVID-19 Gene Sequence Raises Valid Question or “Quirky Observation?”

  Researchers identified a 19-nucleotide- long RNA sequence found in the SARS-CoV-2’s furin cleavage site that matched a 19-nucleotide sequence in a genetic segment owned by Moderna.

  February 24, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Takeda-Backed Biotech Grabs $24 Million for tRNA-Based Therapies

  With two proprietary platforms dedicated to developing tRNA-based therapeutics targeting protein dysfunction, hC Bio aims to develop precision protein editing technology to cure genetic diseases.

  February 24, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Research Roundup: Neurons Key to Parkinson’s ID’ed, New ALS Mechanism Discovered

  There’s always more to learn about Parkinson’s, and researchers discovered a specialized group of neurons associated with the disease.

  February 24, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Martin Shkreli Banned Again - This Time from Running Public Companies

  After Judge Denise Cotes banned Martin Shkreli from future involvement in the industry, a second judge handed down a similar order and ordered him to pay a $1.39 million fine.

  February 24, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Medicago’s Plant-Based Vaccine Bolstered by GSK Adjuvant Wins First Approval

  Not only is this the first approval for a plant-based vaccine, it’s also the first approval for GSK’s adjuvant.

  February 24, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Research Collab Uncovers Underlying Mechanism for ALS and Dementia

  Researchers have unlocked a key mechanism behind the gene encoding protein UNC13A which could provide new treatment options for ALS and FTD.

  February 24, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  COVID-19 Update: Omicron BA.2 Raises Questions, FDA Limits GSK Antibody

  The new normal may not be particularly new. Although cases appear to be dropping — deaths in the unvaccinated are still high. For that and more COVID-19 stories, continue reading.

  February 24, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers, Feb. 25

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  February 24, 2022

   · 

  7 min read

   · 

  Alex Keown
• 

  BioMidwest

  Gut Health: CRISPR-Based Kill Switch Causes Bacteria to Self-Destruct

  The researchers note that engineered strains of EcN have been used to diagnose and treat bacterial infections, cancers, gastrointestinal bleeding, inflammatory disorders, and obesity.

  February 24, 2022

   · 

  5 min read

   · 

  Abbey Glasure